The role of peptide YY in regulating glucose homeostasis

Peptides

Volumn 28, Issue 2, 2007, Pages 390-395

  Boey, Dana ^a   Sainsbury, Amanda ^a   Herzog, Herbert ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Glucose; Insulin; Peptide YY; Type II diabetes

Indexed keywords

GLUCOSE; INSULIN; PEPTIDE YY;

BODY WEIGHT; DIGESTIVE FUNCTION; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SATIETY; SYSTEMATIC REVIEW;

ANIMALS; CLINICAL TRIALS; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; PEPTIDE YY;

ANIMALIA;

EID: 33846612846     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.07.031     Document Type: Review

References (54)

1. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., and Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89 (1985) 1070-1077
2. Adrian T.E., Sagor G.R., Savage A.P., Bacarese-Hamilton A.J., Hall G.M., and Bloom S.R. Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. J Clin Endocrinol Metab 63 (1986) 803-807
3. Adrian T.E., Savage A.P., Sagor G.R., Allen J.M., Bacarese-Hamilton A.J., Tatemoto K., et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89 3 (1985) 494-499
4. Ahren B., and Larsson H. Peptide YY does not inhibit glucose-stimulated insulin secretion in humans. Eur J Endocrinol 134 3 (1996) 362-365
5. 3-36. New Engl J Med 349 10 (2003) 941-948
6. 3-36 physiologically inhibits food intake. Nature 418 6898 (2002) 650-654
7. Bertrand G., Gross R., Rove M., Ahren B., and Ribes G. Evidence for a direct inhibitory effect of PYY on insulin secretion in rats. Pancreas 5 5 (1992) 595-600
8. Bhavsar S., Parkes D., Hoyt J., Reynolds J., Paterniti Jr. J.R., and Young A. PYY[3-36] decreases food consumption and improves glycemic control in Zucker diabetic fatty (ZDF) rats. Diabetes 51 1 (2002) A418-A419
9. Blomqvist A.G., and Herzog H. Y-receptor subtypes-how many more?. Trends Neurosci 20 (1997) 294-298
10. Boey D., Heilbronn L., Laybutt D.R., Kriketos A.D., Herzog H., and Campbell L.V. Low serum PYY is linked to insulin reistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides 40 5 (2006) 317-324
11. Boey D., Lin S., Karl T., Baldock P., Lee N., Enriquez R., et al. Peptide YY ablation in mice leads to the development of hyperinsulinemia and obesity. Diabetologia 49 6 (2006) 1360-1370
12. Bottcher G., Ahren B., Lundquist I., and Sundler F. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse. Pancreas 4 3 (1989) 282-288
13. Burcelin R., Brunner H., Seydoux J., Thorens B., and Pedrazzini T. Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. Peptides (2001) 421-427
14. Castan I., Valet P., Larrouy D., Voisin T., Remaury A., Daviaud D., et al. Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the α-adrenergic system. Am J Physiol Endocrinol Metab 28 (1993) E74-E80
15. Chelikani P.K., Haver A.C., and Reidelberger R.D. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146 2 (2005) 879-888
16. Ekblad E., and Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 23 (2002) 251-261
17. English P.J., Gillett A., Dovey T., Halford J.C.G., Paterson M.A., Bloom S.R., et al. Evidence for PYY 3-36 resistance in type 2 diabetes. Diab Med 21 Suppl. 2 (2004) 36-108
18. Grandt D., Schimiczek M., Rascher W., Feth F., Shively J., Lee T.D., et al. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognising PYY 1-36 and PYY 3-36. Regul Pept 51 (1994) 151-159
19. Greeley G.H., Lluis F., Gomez G., Ishizuka J., Holland B., and Thompson J.C. Peptide YY antagonizes β-adrenergic-stimulated release of insulin in dogs. Am J Physiol 254 (1988) E513-E517
20. Guo Y.S., Singh P., DeBouno J.F., and Thompson J.C. Effect of peptide YY on insulin release stimulated by 2-deoxyglucose and neuropeptides in dogs. Pancreas 3 2 (1988) 128-134
21. Guo Y.S., Singh P., Draviam E., Greeley G.H., and Thompson J.C. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide. Gastroenterology 93 3 (1989) 690-694
22. Hernandez E.J., Whitcomb D.C., Vigna S.R., and Taylor I.L. Saturable binding of circulating peptide YY in the dorsal vagal complex of rats. Am J Physiol Gastrointest Liver Physiol 266 (1994) 511-516
23. Hoetjen F., Hopman W.P., and Jansen J.B. Effect of circulating peptide YY on gallbladder emptying in humans. Scand J Gastroenterol 36 10 (2001) 1086-1091
24. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
25. Karlsson S., and Ahren B. A role for islet peptide YY in the regulation of insulin secretion. Acta Physiol Scand 157 (1996) 305-306
26. Kezanjian K.K., Towfigh S., and McFadden D.W. Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro. J Surg Res 114 (2003) 95-99
27. Kim B., Carlson O., Jang H., Elahi D., Berry C., and Egan J.M. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab 90 12 (2005) 6665-6671
28. Kim K.R., Nam S.Y., Song Y.D., Lim S.K., Lee H.C., and Huh K.B. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone. Hormone Res 51 2 (1999) 78-84
29. Korner J., and Leibel R.L. To eat or not to eat-how the gut talks to the brain. New Engl J Med 349 10 (2003) 926-928
30. Lundberg J.M., Tatemoto K., Terenius L., Hellstrom P.M., Mutt V., Hokfelt T., et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 79 (1982) 4471-4475
31. Lynch D.R., Walker M.W., Miller R.J., and Snyder S.H. Neuropeptide Y receptor binding sites in rat brain: differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity. J Neurosci 9 (1989) 2607-2619
32. Marks J.L., and Wait K. Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. J Neuroendocrinol 9 (1997) 99-103
33. Matsuda H., Brumovsky P.R., Kopp J., Pedrazzini T., and Hokfelt T. Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues. J Comp Neurol 449 4 (2002) 390-404
34. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 401-411
35. McIntosh C.H., Demuth H., Pospisilik J.A., and Pederson R. Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?. Regul Pept (2005) 159-165
36. Moore C., Jodka C., Dang J., Lwin A., and Young A. Chronic administration of PYY[3-36] reduces body weight and improves glycemic control in C57BL/6J mice fed a high fat diet. Diabetes 51 1 (2002) A418-A419
37. Naruse S., Kitagawa M., Ishiguro H., and Hayakawa T. Feedback regulation of pancreatic secretion by peptide YY. Peptides 23 (2002) 359-365
38. Nieuwenhuizen A.G., Karlsson S., Fridolf T., and Ahren B. Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets. Diabetologia 37 (1994) 871-878
39. Okuno M., Nakanishi T., Shinomura Y., Koyohara T., Ishikawa H., and Tarui S. Peptide YY enhances NaCl and water absorption in the rat colon in vivo. Experientia 48 (1991) 48-50
40. Onaga T., Zabielski R., and Kato S. Multiple regulation of peptide YY secretion in the digestive tract. Peptides (2002) 279-290
41. Pieribone V.A., Brodin L., Friberg K., Dahlstrand J., Soderberg C., Lahammar D., et al. Differential expression of mRNAs for neuropeptide Y-related peptides in rat nervous tissues: possible evolutionary conservation. J Neurosci 12 9 (1992) 3361-3371
42. Pittner R., Moore C., Bhavsar S., Gedulin B., Smith P., Jodka C., et al. Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes 28 8 (2004) 963-971
43. Renshaw D., and Batterham R.L. Peptide YY: a potential therapy for obesity. Curr Drug Targets 6 2 (2005) 171-179
44. Stock S., Leichner P., Wong A.C.K., Ghatei M.A., Kieffer T.J., Bloom S.R., et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90 4 (2005) 2161-2168
45. Szecowka J., Tatemoto K., Rajamaki G., and Efendic S. Effects of PYY and PP on endocrine pancreas. Acta Physiol Scand 119 2 (1983) 123-126
46. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79 (1982) 2514-2518
47. Torekov S.S., Larsen L.H., Glumer C., Borch-Johnsen K., Jorgensen T., Holst J.J., et al. Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes. Diabetes 54 (2005) 2261-2265
48. Upchurch B.H., Aponte G.W., and Leiter A.B. Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 120 (1994) 245-252
49. Upchurch B.H., Fung B.P., Rindi G., Ronco A., and Leiter A.B. Peptide YY expression is an early event in colonic endocrine cell differentiation: evidence from normal and transgenic mice. Development 122 (1996) 1157-1163
50. van den Hoek A.M., Heijboer A.C., Corssmit E.P.M., Voshol P.J., Romijn J.A., Havekes L.M., et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53 (2004) 1949-1952
51. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
52. Yoshinaga K., Mochizuki T., Yanaihara N., Oshima K., Izukura M., Kogire M., et al. Structural requirements of peptide YY for biological activity at enteric sites. Am J Physiol 26 (1992) G695-G701
53. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., and Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133 (1993) 1753-1758
54. Cho Y.R., and Kim C.W. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation. Biochem Biophys Res Commun 314 3 (2004) 773-780